Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Neurocognitive Changes in Chronic Hepatitis C Patients Receiving Combination Therapy of Interferon and Ribavirin: A Systematic Review
Current Drug Therapy
October 2022
Wani M.A.
Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
Caspian Journal of Internal Medicine
2020
Sharafi H.
Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
Microbial Drug Resistance
September 2019
Sharafi H.
Sofosbuvir and ribavirin with or without pegylated-interferon in hepatitis C virus genotype-2 or -3 infections: A systematic review and meta-analysis
Archives of Clinical Infectious Diseases
February 2019
Bayatpoor M.E.
Open Access
Hepatitis B and hepatitis C in patients with inherited disorders of hemoglobin in sistan and baluchistan province, Iran
Archives of Clinical Infectious Diseases
December 2018
Khosravi S.
Open Access
A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms
Journal of Clinical Laboratory Analysis
September 2018
Alavian S.E.
Open Access
Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
World Journal of Hepatology
2018
Sharafi H.
Open Access
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
Journal of the Formosan Medical Association
January 2018
Liang P.C.
Open Access
Update on recommendations for the clinical management of hepatitis C in Iran 2017
Hepatitis Monthly
November 2017
Alavian S.M.
Open Access
Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C
Journal of Clinical Laboratory Analysis
July 2017
Keshvari M.
Open Access
Efficacy and safety of generic sofosbuvir/ledipasvir fixed-dose combination in Iranian patients with chronic hepatitis C virus infection
Hepatitis Monthly
June 2017
Sharafi H.
Open Access
Assessment of hepatitis C virus RNA in peripheral blood mononuclear cells as a predictor of response to pegylated-interferon and ribavirin: A cohort study
Iranian Red Crescent Medical Journal
May 2017
Miri S.M.
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: A systematic review and meta-analysis
Daru Journal of Pharmaceutical Sciences
20 April 2017
Dolatimehr F.
Open Access
The role of polymorphisms near IFNL3 gene as predictors of residual HCV RNA in buffy coat after successful antiviral therapy
Hepatitis Monthly
1 April 2017
Miri S.M.
Open Access
A simple PCR-RFLP method for genotyping of IFNL4 rs368234815 polymorphism in patients with chronic hepatitis C
Lab Medicine
February 2017
Pouryasin M.
Open Access
Genetic variation in interleukin-28B and response to Peg-IFNα-2a/RBV combination therapy in patients with hepatitis C virus infection
Jundishapur Journal of Microbiology
January 2017
Bokharaei-Salim F.
Open Access
Molecular tracing of hepatitis C virus genotype 1 isolates in Iran: A NS5B phylogenetic analysis with systematic review
Hepatitis Monthly
1 December 2016
Hesamizadeh K.
Open Access
Recommendations for the clinical management of hepatitis C in Iran: A consensus-based national guideline
Hepatitis Monthly
August 2016
Alavian S.M.
Open Access
Next steps toward eradication of hepatitis C in the era of direct acting antivirals
Hepatitis Monthly
18 April 2016
Hesamizadeh K.
Open Access